On the 7 day of this study an antiaggregant effect with CPDG was found among patients who had received PPIs. Their average rate of platelet reactivity PR was detected at 39.8% while it was 51.4% for patients who had received placebos p<0.0001.
En este estudio se encontró que los pacientes que recibieron IBP tuvieron efecto antiagregante con CPDG al encontrar que en el día 7, el índice de reactividad plaquetaria IRP fue de 39,8% versus 51,4% en los que recibieron placebo p<0,0001.